Immunotherapeutic Approaches in Cancer Treatment

Author(s): Lihong Zhao, Lili Zhong, Songbai Xu, Bingjin Li*.

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Volume 19 , Issue 2 , 2019

Become EABM
Become Reviewer

[1]
Wei, S.C.; Duffy, C.R.; Allison, J.P. Fundamental mechanisms of immune checkpoint blockade therapy. Cancer Discov., 2018, 8(9), 1069-1086.
[2]
Constantinidou, A.; Alifieris, C.; Trafalis, D.T. Targeting Programmed Cell Death -1 (PD-1) and Ligand (PD-L1): A new era in cancer active immunotherapy. Pharmacol. Ther., 2019, 194, 84-106.
[3]
Rowshanravan, B.; Halliday, N.; Sansom, D.M. CTLA-4: A moving target in immunotherapy. Blood, 2018, 131(1), 58-67.
[4]
Gide, T.N.; Wilmott, J.S.; Scolyer, R.A.; Long, G.V. Primary and acquired resistance to immune checkpoint inhibitors in metastatic melanoma. Clin. Cancer Res., 2018, 24(6), 1260-1270.
[5]
Grivas, P.; Koshkin, V.S.; Pal, S.K. Cancer vaccines at the age of immune checkpoint inhibitors: Reasonable approach as combination therapy in advanced urothelial carcinoma? Ann. Oncol., 2017, 28(4), 680-682.
[6]
Hu, Y.; Lu, L.; Xia, Y.; Chen, X.; Chang, A.E.; Hollingsworth, R.E.; Hurt, E.; Owen, J.; Moyer, J.S.; Prince, M.E.; Dai, F.; Bao, Y.; Wang, Y.; Whitfield, J.; Xia, J.C.; Huang, S.; Wicha, M.S.; Li, Q. Therapeutic efficacy of cancer stem cell vaccines in the adjuvant setting. Cancer Res., 2016, 76(16), 4661-4672.
[7]
Zhang, X.; Sharma, P.K.; Peter Goedegebuure, S.; Gillanders, W.E. Personalized cancer vaccines: Targeting the cancer mutanome. Vaccine, 2017, 35(7), 1094-1100.
[8]
Tao, P.; Mahalingam, M.; Zhu, J.; Moayeri, M.; Sha, J.; Lawrence, W.S.; Leppla, S.H.; Chopra, A.K.; Rao, V.B.A. Bacteriophage T4 nanoparticle-based dual vaccine against anthrax and plague. MBio, 2018, 9(5), e01926-e01918.
[9]
Bao, Q.; Li, X.; Han, G.; Zhu, Y.; Mao, C.; Yang, M. Phage-based vaccines. Adv. Drug Deliv. Rev., 2018.
[10]
Bartolacci, C.; Andreani, C.; Curcio, C.; Occhipinti, S.; Massaccesi, L.; Giovarelli, M.; Galeazzi, R.; Iezzi, M.; Tilio, M.; Gambini, V.; Wang, J.; Marchini, C.; Amici, A. Phage-based anti-HER2 vaccination can circumvent immune tolerance against breast cancer. Cancer Immunol. Res., 2018, 6(12), 1486-1498.
[11]
Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell, 2011, 144(5), 646-674.
[12]
Hanahan, D.; Coussens, L.M. Accessories to the crime: Functions of cells recruited to the tumor microenvironment. Cancer Cell, 2012, 21(3), 309-322.
[13]
Qian, B.Z.; Pollard, J.W. Macrophage diversity enhances tumor progression and metastasis. Cell, 2010, 141(1), 39-51.
[14]
Lewis, C.E.; Harney, A.S.; Pollard, J.W. The multifaceted role of perivascular macrophages in tumors. Cancer Cell, 2016, 30(1), 18-25.
[15]
De Palma, M.; Biziato, D.; Petrova, T.V. Microenvironmental regulation of tumour angiogenesis. Nat. Rev. Cancer, 2017, 17(8), 457-474.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 2
Year: 2019
Page: [204 - 205]
Pages: 2
DOI: 10.2174/187152061902190418105255

Article Metrics

PDF: 19
HTML: 3

Special-new-year-discount